Inventiveness is undoubtedly the focal point of dispute in patentability adjudication. No “single standard” may be adopted in determining patent inventiveness.
Due to the unique characteristics of drug development, usually only one active compound would be selected from tens of thousands of candidates for use for medicinal purposes.
京公网安备 11010802020770号